SearchInternal medicine trials are highly specialized
Flexible and tailored strategies to ensure success
Clinical trials within internal medicine are highly specialized and varied, requiring tailored approaches to ensure success. At IQVIA Biotech, we recognize the need for customized strategies across different subspecialties. Our team of therapeutically aligned experts have extensive experience in various fields, enabling us to develop and implement optimal clinical strategies.
Whether it's a cystic fibrosis trial or an ulcerative colitis trial, we understand the unique nuances, including regulatory requirements, trial design, standards of care, and competitive landscape. With established relationships with key opinion leaders in each specialty area, we are well-equipped to navigate the complexities of your clinical trial.
We share the passion that our biotech partners have for the development of cutting-edge products, and we are proud to play a role in the design and execution of successful clinical trials that get innovative treatments to patients.
Internal medicine expertise
Utilizing our broad therapeutic expertise and adaptable operational approach, along with access to IQVIA's unparalleled data resources, enables us to collaborate closely with biotech partners and ultimately maximize patient impact.
Subspecialties
|
|
OUR LATEST THINKING
Leverage the power of real world data
Through advanced analytics, such as artificial intelligence and machine learning, coupled with our therapeutic expertise, IQVIA Commercial Solutions can help track the impact of clinical advancements in real world diagnosis and treatment patterns. By accelerating time to insights we help customers drive business decisions which, ultimately, impact patient care.
Connected Intelligence for smart clinical development
By making intelligent connections across an expansive portfolio of capabilities, unparalleled data and therapeutic expertise, we bring innovation to the needs of modern clinical research and drug development to help you focus on the patient, manage trial complexity, and increase predictability and speed.
Generate and disseminate the right real world evidence (RWE) to meet stakeholder needs with confidence.
Drive cell and gene therapy development from candidate identification through market authorization.
Connect data, analytics, domain expertise, and technology to uncover actionable insights and maximize commercial effectiveness.